ICLRICON Public Limited Company
Is it growing?
Growth is fading: earnings down −95% year on year and operating margin narrowing (−9.8 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +21% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 3.6% now against 13.4% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ICLR growing?
ICON Public Limited Company has grown revenue 1.7% a year over three years and 21% a year over five, with earnings per share compounding at −56%.
Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +21%
Revenue growth, 5-year rate · +1.7% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −56%
Earnings per share, 3-year rate · revenue +1.7% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $5.48B
- Revenue FY2022
- $7.74B
- Revenue FY2023
- $8.05B
- Revenue FY2024
- $8.19B
- Revenue FY2025
- $8.25B
Annual income statements as filed with the SEC.
Diagnostics & Research
Ranks #3 of 21 by RyuScore